Healthy volunteers test new gastric ulcer drug formulations
NCT ID NCT07385235
First seen Feb 04, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This early-stage study tests two versions of a drug for stomach ulcers in 46 healthy adults. Participants receive a single dose of either AD-115A or AD-1151, and researchers measure how the drug moves through the body and check for side effects. The goal is to compare the two formulations, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ULCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
H PLUS YANGJI HOSPITAL, Seoul
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.